相似文献/References:
[1]陈姝,李文,罗云,等.减低剂量Bu+Cy预处理方案进行异基因造血干细胞移植治疗白血病的效果观察[J].陆军军医大学学报(原第三军医大学学报),2012,34(24):2442.
Chen Shu,Li Wen,Luo Yun,et al.Therapeutic effect of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen of Bu+Cy for leukemia[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(12):2442.
[2]刘嘉,高蕾,张曦,等.异基因造血干细胞移植联合伊马替尼治疗成人Ph+急性淋巴细胞白血病临床观察[J].陆军军医大学学报(原第三军医大学学报),2012,34(24):2453.
Liu Jia,Gao Lei,Zhang Xi,et al.Clinical efficiency of allogenic hematopoietic stem cell transplantation combined with imatinib in treatment of Philadelphia positive acute lymphoblastic leukemia[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(12):2453.
[3]苏毅,赖思含,易海,等.异基因造血干细胞移植术治疗自体造血干细胞移植术后复发的恶性淋巴瘤17例效果分析[J].陆军军医大学学报(原第三军医大学学报),2012,34(24):2456.
Su Yi,Lai Sihan,Yi Hai,et al.Allogeneic hematopoietic stem cell transplantation for recurrent lymphoma after autologous stem cell transplantation: clinical analysis of 17 cases[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(12):2456.
[4]梁雪,陈幸华,孔佩艳,等.异基因造血干细胞移植后肠道移植物抗宿主病临床分析[J].陆军军医大学学报(原第三军医大学学报),2009,31(21):2158.
[5]颜红菊,唐伦,高蕾,等.单倍体与同胞全相合造血干细胞移植治疗高危急性淋巴细胞白血病疗效观察[J].陆军军医大学学报(原第三军医大学学报),2016,38(12):1340.
Yan Hongju,Tang Lun,Gao Lei,et al.Efficacy of haploid-matched vs sibling-matched allogeneic stem cell transplantation for high risk acute lymphoblastic leukemia[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(12):1340.
[6]刘红云,陈果,曾韫璟,等.脐带间充质细胞对异基因造血干细胞移植术后出血性膀胱炎的疗效及安全性分析[J].陆军军医大学学报(原第三军医大学学报),2019,41(23):2296.
LIU Hongyun,CHEN Guo,ZENG Yunjing,et al.Efficiency and safety of umbilical cord mesenchymal stromal cell infusion in treatment of hemorrhagic cystitis after allogenic hematopoietic stem cell transplantation[J].J Amry Med Univ (J Third Mil Med Univ),2019,41(12):2296.
[7]蔺诗佳,刘雨青,姚浛,等.EVI1基因阳性的急性髓系白血病患者临床特点及其造血干细胞移植的疗效观察[J].陆军军医大学学报(原第三军医大学学报),2020,42(17):1699.
LIN Shijia,LIU Yuqing,YAO Han,et al.Clinical characteristics of EVI1+ AML and clinical observation of hematopoietic stem cell transplantation on these patients[J].J Amry Med Univ (J Third Mil Med Univ),2020,42(12):1699.
[8]陆铉,严晗,夏凌辉.缬更昔洛韦抢先治疗异基因造血干细胞移植后巨细胞病毒血症的临床研究[J].陆军军医大学学报(原第三军医大学学报),2020,42(17):1706.
LU Xuan,YAN Han,XIA Ling.Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation[J].J Amry Med Univ (J Third Mil Med Univ),2020,42(12):1706.
[9]张艳芳,娄世峰,陈姝,等.泊沙康唑在异基因造血干细胞移植期间预防侵袭性真菌病的效果和安全性:单中心回顾性分析[J].陆军军医大学学报(原第三军医大学学报),2021,43(21):2307.
HANG Yanfang,LOU Shifeng,CHEN Shu,et al.Efficacy and safety of posaconazole in prevention of invasive fungal infections during allogeneic hematopoietic stem cell transplantation: a single-center retrospective analysis[J].J Amry Med Univ (J Third Mil Med Univ),2021,43(12):2307.
[10]何云地,黄瑞昊,洪涛,等.西罗莫司和伊马替尼治疗激素难治性慢性移植物抗宿主病的临床观察:一项单中心回顾性分析[J].陆军军医大学学报(原第三军医大学学报),2021,43(21):2313.
HE Yundi,HUANG Ruihao,HONG Tao,et al.Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center[J].J Amry Med Univ (J Third Mil Med Univ),2021,43(12):2313.